Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)

1
Industry Research by Koncept Analytics
Global Erythropoietin (EPO) Market with Focus on
Asia Industry Analysis Outlook
-----------------------------------------
(2016-2020)
November 2016
2
Executive Summary
Erythropoietin is a substance produced by the
kidney that leads to the formation of red blood
cells in the bone marrow. It is a glycoprotein
hormone which regulates erythropoiesis (Red Blood
Cell production). For erythrocyte precursors
present in the bone marrow, EPO acts as a
cytokine. Commonly referred to as hematopoietin
or hemopoietin, erythropoietin is also known to
have other biological functions, such as
involvement in the wound healing cycle and
brains response to neuronal injury. People
suffering from End Stage Renal Disease (ESRD),
HIV or undergoing chemotherapy are not able to
produce enough EPO on their own and thus, are
administered with synthetic or recombinant
erythropoietin which has the similar sequence of
amino acids. Recombinant erythropoietin is a kind
of therapeutic agent devised using DNA
technology. On the bases of their molecular
structure, EPO drugs can be divided into five
categories epoetin-alfa, epoetin-beta,
epoetin-omega, epoetin-delta and
darbepoetin-alfa. Among these epoetin-alfa and
darbepoetin-alfa are most commonly prescribed EPO
drugs. The global EPO drugs market is expected to
experience negative growth rate, primarily due to
expiry of patents of two most common EPO drugs,
epoetin-alfa and darbepoetin-alfa, allowing the
entry of biosimilars posing a serious threat to
EPO drugs market. However, the Asia-Pacific
region is expected to experience boom period
majorly due to improving disposable income and
better government medical reimbursement
policies. The report Global Erythropoietin (EPO)
Market with Focus on Asia Industry Analysis
Outlook (2016-2020) analyzes the development of
this market, with focus on the US and
Asia-Pacific markets. The major trends, growth
drivers as well as issues being faced by the
market are discussed in detail in this report.
The four major players Johnson Johnson, Amgen,
Roche and Teva Pharmaceutical Industries Limited
are being profiled along with their key
financials and strategies for growth. The report
contains a comprehensive analysis of the global
EPO market along with the study of the regional
markets.
3
Globally rising incidences of cancer, End Stage
Renal Disease (ESRD) and other chronic ailments
would expectedly drive growth of the global EPO
market. However, the expiry of patents of
epoetin-alfa in year 2015 and darbepoetin-alfa in
late 2016 will have a negative impact on the
overall market growth.
Global EPO Drug Market by Value (2011-2015)

• The global EPO market reached US... billion by
  the end of year 2015, recording a mild decline of
  . from previous years revenue of US...
  billion.
• In 2016, the global EPO market will reach US...
  billion and is expected to fall to US... billion
  mark by 2020, declining at a CAGR of , spanning
  from 2016 to 2020.
• In year 2015, the US held share of the global
  EPO drug market followed by Asia-Pacific with
  merely share. However, by the end of year
  2020, the market share of the US will fall to
  and Asia-Pacific will rise to .

Global EPO Drug Market by Value Forecast
(2016-2020)
Global EPO Drug Market by Region (2015/2020)
2020
2015
4
The Asia-Pacific region is expected to experience
boom period majorly due to improving disposable
income and better government medical
reimbursement policies.
The US EPO Drug Market by Value Forecast
(2015-2020)

• In 2015, the market was recorded at US...
  billion and is expected to fall to nearly US...
  billion by the end of 2020, declining at a CAGR
  of , spanning from 2015 to 2020.
• In 2015, the China EPO market was recorded at
  US... billion, compared to US... billion in
  2014, representing an annual increment of nearly
  from the previous year.
• In 2015, the EPO market value of Malaysia was
  recorded at US... million and is further
  expected to accelerate at an impressive CAGR of
  , spanning from 2015 to 2020 and reach US...
  million by the end of 2020.

China EPO Drug Market by Value (2011-2015)
Malaysia EPO Drug Market by Value Forecast
(2015-2020)
5
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com